Main public logs
Combined display of all available logs of Compendium of Cancer Genome Aberrations. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 10:54, 18 April 2021 127.0.0.1 talk set 9901 as the approved revision for "Histiocytic and Dendritic Cell Neoplasms"
- 10:54, 18 April 2021 127.0.0.1 talk set 7897 as the approved revision for "Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 7896 as the approved revision for "Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder"
- 10:54, 18 April 2021 127.0.0.1 talk set 7895 as the approved revision for "Monomorphic T/NK-cell PTLD"
- 10:54, 18 April 2021 127.0.0.1 talk set 7894 as the approved revision for "Monomorphic B-cell PTLD"
- 10:54, 18 April 2021 127.0.0.1 talk set 7893 as the approved revision for "Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)"
- 10:54, 18 April 2021 127.0.0.1 talk set 7892 as the approved revision for "Polymorphic Post-Transplant Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 7891 as the approved revision for "Non-Destructive Post-Transplant Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 9900 as the approved revision for "Post-Transplant Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 7889 as the approved revision for "Lymphomas Associated with HIV Infection"
- 10:54, 18 April 2021 127.0.0.1 talk set 7574 as the approved revision for "Lymphoproliferative Diseases Associated with Primary Immune Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 7571 as the approved revision for "PTLD"
- 10:54, 18 April 2021 127.0.0.1 talk set 9899 as the approved revision for "Immunodeficiency-Associated Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 7887 as the approved revision for "Lymphocyte-Depleted Classic Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7886 as the approved revision for "Mixed Cellularity Classic Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7885 as the approved revision for "Lymphocyte-Rich Classic Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7884 as the approved revision for "Nodular Sclerosis Classic Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9898 as the approved revision for "Classic Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7882 as the approved revision for "Nodular Lymphocyte Predominant Hodgkin Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9897 as the approved revision for "Hodgkin Lymphomas"
- 10:54, 18 April 2021 127.0.0.1 talk set 8862 as the approved revision for "Breast Implant-Associated Anaplastic Large Cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9576 as the approved revision for "Anaplastic Large Cell Lymphoma, ALK-Negative"
- 10:54, 18 April 2021 127.0.0.1 talk set 9573 as the approved revision for "Anaplastic Large Cell Lymphoma, ALK-Positive"
- 10:54, 18 April 2021 127.0.0.1 talk set 9619 as the approved revision for "Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype"
- 10:54, 18 April 2021 127.0.0.1 talk set 7876 as the approved revision for "Follicular T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9896 as the approved revision for "Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin"
- 10:54, 18 April 2021 127.0.0.1 talk set 7873 as the approved revision for "Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)"
- 10:54, 18 April 2021 127.0.0.1 talk set 7872 as the approved revision for "Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder"
- 10:54, 18 April 2021 127.0.0.1 talk set 7871 as the approved revision for "Primary Cutaneous Acral CD8+ T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7870 as the approved revision for "Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7869 as the approved revision for "Primary Cutaneous Gamma Delta T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9895 as the approved revision for "Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes"
- 10:54, 18 April 2021 127.0.0.1 talk set 7867 as the approved revision for "Primary Cutaneous Anaplastic Large Cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7866 as the approved revision for "Lymphomatoid Papulosis"
- 10:54, 18 April 2021 127.0.0.1 talk set 9894 as the approved revision for "Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders"
- 10:54, 18 April 2021 127.0.0.1 talk set 10072 as the approved revision for "Volunteers"
- 10:54, 18 April 2021 127.0.0.1 talk set 9522 as the approved revision for "Sézary Syndrome"
- 10:54, 18 April 2021 127.0.0.1 talk set 9617 as the approved revision for "Mycosis Fungoides"
- 10:54, 18 April 2021 127.0.0.1 talk set 7862 as the approved revision for "Subcutaneous Panniculitis-Like T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9429 as the approved revision for "Hepatosplenic T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 8935 as the approved revision for "Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract"
- 10:54, 18 April 2021 127.0.0.1 talk set 8458 as the approved revision for "Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)"
- 10:54, 18 April 2021 127.0.0.1 talk set 8895 as the approved revision for "Monomorphic Epitheliotropic Intestinal T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9504 as the approved revision for "Enteropathy-Associated T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 9893 as the approved revision for "Intestinal T-cell Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7855 as the approved revision for "Extranodal NK/T-cell Lymphoma, Nasal Type"
- 10:54, 18 April 2021 127.0.0.1 talk set 9906 as the approved revision for "Adult T-cell Leukemia/Lymphoma"
- 10:54, 18 April 2021 127.0.0.1 talk set 7853 as the approved revision for "Severe Mosquito Bite Allergy"
- 10:54, 18 April 2021 127.0.0.1 talk set 7852 as the approved revision for "Hydroa Vacciniforme-Like Lymphoproliferative Disorder"
- 10:54, 18 April 2021 127.0.0.1 talk set 7851 as the approved revision for "Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form"